Imperial Bioscience


Biopharmaceutical company developing and commercialising dissolving microneedle (microarray patch) technologies for transdermal delivery of cosmeceutical and pharmaceutical actives. The organisation focuses on R&D of hyaluronic acid–based self‑dissolving microstructures, manufacturing processes for microarray patches, clinical evaluation of patch efficacy, and commercialisation of skincare product lines. The company publishes clinical studies and has received public translational R&D funding to progress preclinical programmes toward clinical stages.

Industries

biopharma
life-science
medical
pharmaceutical

Nr. of Employees

small (1-50)

Imperial Bioscience


Products

Cosmetic microneedle patch product line (consumer skincare kits)

Consumer-facing dissolving microneedle patch kits formulated with vegAN-friendly actives and hyaluronic acid–based micro‑structures to address skin concerns such as fine lines, hyperpigmentation, blemishes and scarring.


Services

Customisable dissolving microneedle platform development and licensing

Platform development and partnership/licensing opportunities to adapt dissolving microneedle patches for different active ingredients and indications.

Expertise Areas

  • Transdermal drug delivery
  • Microneedle/microarray patch development
  • Formulation of biomolecules for transdermal delivery
  • Cosmeceutical product development
  • Show More (4)

Key Technologies

  • Dissolving microneedle / microarray patch platforms
  • Hyaluronic acid–based dissolvable microstructures
  • Droplet‑extension (DEN) microfabrication for patches
  • Encapsulation and stabilization of peptides and biomolecules in patch matrices
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.